8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)
X4 Pharmaceuticals, Inc（CIK 0001501697）于 2026-10-29 向 SEC 提交 8-K 文件，报告日期为 2026-10-29，文件包含 Item 8.01（其他事件）和 Item 9.01（财务报表与附件），共 46 份文件。公司地址为马萨诸塞州波士顿北比肯街 61 号 4 层，SIC 行业分类为 2836 生物制品（非诊断物质）。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 09:59:45
Documents
46
Period of Report
2026-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)
EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 261498137
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov